|
H1N1
Vaccines Locations - Los Angeles, CA
|
|
NEWS: Studies investigate the link between
HVAC and Disease.
When public officials are deciding what
steps to take against the second wave of
the H1N1 virus, known as the swine flu,
new information is available between
airborne diseases and the our building's
central air and heating systems.
The new report from the American Society
of Heating, Refrigeration and air
conditioning engineers (ASHREA),
Infectious Disease Position Document,
implies that ventilation is a main
vector of diseases transmission.
Known information about influenza
transmission usually occurs through
droplet transmission or direct contact.
New data suggest that influenza
transmission occurs through an airborne
route, implicating HVAC systems.
ASHREAS goal
of this following document is to use
health science, combined with
engineering practices and principals to
identify how changes can be made in the
HVAC system to prevent the transmission
of the disease through the air.
The three
known methods of transmission are large
droplet nuclei (>10M), direct contact
and smaller droplet nuclei (<10m).
Personal hygiene, using handkerchiefs or
masks, has been a direct control
strategy for the coughing and sneezing
that produces droplet nuclei CDC 2001.
The known dispersion patterns a cough or
sneeze may also travel through the
airborne route, as data suggest, HVAC
systems may contribute to disease
transmission.
Ventilation
represents a primary infectious disease
control strategy through dilution of
room air around a source (CDC 2005).
Solutions of
interest include; dilution ventilation,
differential room pressurization, room
flow regimes, source capture,
filtration, UV irradiation, or source
capture ventilation.
Directed supply and / or exhaust
ventilation such as laminar flow and
displacement is important in several
settings including operating rooms (AIA
2006).
LEFT Picture - Vent cover,HVAC. H1N1 Flu Virus
|
|
|
IAQ RADIO: Episode#143; H1N1 Virus; Fact Vs. Fiction
The information provided on this one
hour long "ask the doctor" questionnaire
can answer many questions you have about
the H1N1 virus. Basic and advanced
information is presented by the
physician about viruses, transmission of
viruses and current CDC methods used to
track the H1N1 virus. During the
broadcast the announcers
Cliff "Z Man" Zlotnik,
Joe "Radio Joe" Hughes really helped the
doctor layout as much information as
possible. To listen to the show
please click the radio or the page link
below.
http://www.iaqradio.com/
|
|
|
H1N1 Vaccinations at the following CVS Locations
Inside CVS/Pharmacy #9751
5623 Kanan Road
Agoura, CA 91301
Inside CVS/pharmacy #9576
10889 Wellworth Avenue
Los Angeles, CA 90024
Inside CVS/pharmacy #9615
19353 Victory Boulevard
Reseda, CA 91335
Inside CVS/pharmacy #8871
13171 Mindanao Way
Marina Del Rey, CA 90292
Note:
Currently, the demand for H1N1 vaccine
is outweighing local and national
supply. That’s why some Public Health
vaccine clinics may reach capacity
earlier than expected and need to close
earlier than the posted hours. If you
are not in an H1N1 Priority Group,
please wait to get vaccinated until
vaccine supplies increase. More H1N1
vaccine will be available in the next
several days and weeks at some chain
pharmacies, private health care
providers, and community clinics.sewage back up or broken pipe. Determining if sewage contamination has occurred is a prime public health concern. Some of the potentially harm organism are E.Coli, Shigella, and Salmonella.
As these organism are usually found in low numbers in sewage, other more common types of bacteria have been used as primary indicators. In the past, those organisms are typically coliforms and tota fecal coliforms. These samples were originally used to test clean water samples and are now used to test for bacterial contamination.
H1N1 Facts - www.FunGuyInspections/H1N1-Facts.com
|
|
|
EDUCATION:
H1N1:
Preparedness, Contingency Planning, and
Tips for Auditing
The Auditing Roundtable and AIHA are
pleased to co-present "H1N1:
Preparedness, Contingency Planning, and
Tips for Auditors." This one-hour
webinar will provide brief background on
H1N1 -- what it is, and why it's
different. It will focus on business
issues, preparedness and contingency
plans, testing of plans, safety and
industrial hygiene tips, resources, and
tips on how EHS Auditors can convey
useful information and help manage
safety and business risks.
Mr. Steve Motzko, CSP, manager of EHS at
Simpson Strong-Tie and Tom Fuller, ScD,
CIH, MSPH, MBA and Program Director of
Environmental Health Science at Illinois
State University will be our presenters.
Both gentlemen have presented on this
topic to the Auditing Roundtable and/or
AIHA before, to great acclaim.
Pricing: $60 to the general public,
$50 for members of organizations
affiliated with the Auditing Roundtable,
$40 for Auditing Roundtable or AIHA
members. Registration at
www.auditing-roundtable.org.
Contact
kathy@auditing-roundtable.org
for pricing information if you are a
government employee, in academia full
time, a nonprofit entity, or are
currently unemployed.
Attendees on December 14 will receive 1
CEU credit on successful completion of a
short quiz within two weeks of the
session.
The webinar will be available for
replay at least through March 31, 2009,
at
www.auditing-roundtable.org.
|
|